Loading clinical trials...
Loading clinical trials...
This study will evaluate the potential therapeutic value of two neurosteroid treatments (DHEA and pregnenolone) in the treatment of tobacco withdrawal symptoms. This will include assessing whether the...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Jed E. Rose
NCT00792415 · Substance Withdrawal Syndrome
NCT03374722 · Substance Withdrawal Syndrome, Critical Illness
NCT02801357 · Substance Withdrawal Syndrome, Opiate Addiction, and more
NCT00695864 · Substance Withdrawal Syndrome
NCT00980044 · Substance Withdrawal Syndrome
Duke Center for Nicotine & Smoking Cessation Research
Durham, North Carolina
Duke Center for Nicotine & Smoking Cessation Research
Raleigh, North Carolina
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions